Our results showed that nobiletin, a key active ingredient of C. reticulata, improves myocardial lipid metabolism by directly targeting peroxisome proliferator-activated receptor alpha (PPARα) and inhibiting the phenylephrine (PE)-induced hypertrophic cardiomyopathy responses in vitro. Here, PPARA is linked to hypertrophic cardiomyopathy.